BCG and SARS-CoV-2—What Have We Learned?

Despite controversy over the protective effect of the BCG (Bacille Calmette-Guérin) vaccine in preventing pulmonary tuberculosis (TB) in adults, it has been used worldwide since 1921. Although the first reports in the 1930s had noted a remarkable decrease in child mortality after BCG immunization, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulesza, Jakub, Kulesza, Ewelina, Koziński, Piotr, Karpik, Wojciech, Broncel, Marlena, Fol, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610589/
https://www.ncbi.nlm.nih.gov/pubmed/36298506
http://dx.doi.org/10.3390/vaccines10101641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610589/
https://www.ncbi.nlm.nih.gov/pubmed/36298506
http://dx.doi.org/10.3390/vaccines10101641

Ejemplares similares